Market Overview

40 Stocks Moving In Wednesday's Mid-Day Session



  • Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) shares climbed 32.3% to $21.82. Mirum Pharmaceuticals shares climbed 111% on Monday after the company announced it completed a successful pre-NDA meeting with the FDA for its Maralixibat.
  • Steelcase Inc. (NYSE: SCS) rose 17.6% to $22.43 after the company reported better-than-expected Q3 EPS and sales results.
  • CorMedix, Inc. (NYSE: CRMD) gained 16.5% to $7.63. B. Riley FBR initiated coverage on Cormedix with a Buy rating.
  • Fluent, Inc. (NASDAQ: FLNT) shares jumped 16.4% to $2.5950.
  • Fortress Biotech, Inc. (NASDAQ: FBIO) gained 16% to $2.33. B. Riley initiated coverage on Fortress Biotech with a Buy rating and a $9 price target.
  • Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares climbed 15.8% to $5.35 after the company announced it has entered into a collaboration agreement with Global Blood Therapeutics to discover, develop, and commercialize novel therapies for sickle cell disease and beta thalassemia. GBT will pay Syros $20 million upfront and fund up to $40 million in preclinical research for at least three years.
  • Aptose Biosciences Inc. (NASDAQ: APTO) gained 15.7% to $4.71.
  • LAIX Inc. (NYSE: LAIX) rose 15.5% to $3.7880.
  • Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) gained 14.4% to $10.55. Neoleukin Therapeutics priced its 8.925 million share public offering at $8.40 per share.
  • Stealth BioTherapeutics Corp (NASDAQ: MITO) climbed 12.9% to $13.25.
  • TravelCenters of America Inc. (NASDAQ: TA) jumped 12% to $15.42.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) shares rose 11.9% to $4.14.
  • Noble Corporation PLC (NYSE: NE) shares jumped 11.9% to $1.06. The company named Stephen Butz as Executive Vice President and CFO.
  • Uniti Group Inc. (NASDAQ: UNIT) gained 11.4% to $8.45 after it was announced the company will join the S&P SmallCap 600.
  • DiaMedica Therapeutics Inc. (NASDAQ: DMAC) shares jumped 11.2% to $3.78 after the company disclosed that the first patient has been dosed in REDUX Phase II clinical trial of DM199 for the treatment of chronic kidney disease.
  • comScore, Inc. (NASDAQ: SCOR) gained 9.1% to $5.34.
  • Overseas Shipholding Group, Inc. (NYSE: OSG) climbed 8.5% to $2.29.
  • Sasol Limited (NYSE: SSL) rose 8.4% to $22.53 after Bank of America upgraded the company's stock from Neutral to Buy.
  • LMP Automotive Holdings Inc (NASDAQ: LMPX) climbed 8% to $20.62 after the company entered into a rideshare rental fleet partnership with YayYo Inc.
  • Voya Financial, Inc. (NYSE: VOYA) gained 7.7% to $63.08 after the company entered into an agreement with Resolution Life Group to sell the company's Individual Life and other non-retirment annuities business for roughly $1.7 billion.
  • PG&E Corporation (NYSE: PCG) shares rose 7.3% to $11.71 after a US bankruptcy judge approved the company's $13.5 billion settlement with California wildfire victims.
  • Columbia Sportswear Company (NASDAQ: COLM) gained 7.3% to $101.23. Columbia Sportswear Company will replace Uniti Group in the S&P MidCap 400 on Monday, December 23.
  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 6.4% to $2.48 after surging 12.02% on Tuesday.

Check out these big penny stock gainers and losers


  • Akorn, Inc. (NASDAQ: AKRX) shares fell 21.5% to $2.3801 as traders circulate earlier Seeking Alpha blogpost from Hugh Akston 'Akorn warns of possible bankruptcy filing'.
  • Solid Biosciences Inc. (NASDAQ: SLDB) fell 15% to $4.08 after the company the company reported results from its Phase 1/2 study of SGT-001 that showed the candidate has the potential to provide therapeutic benefit for patients with Duchenne Muscular Dystrophy.
  • Qiwi plc (NASDAQ: QIWI) shares dipped 13% to $18.60 after the company named Boris Kim as CEO, effective January 15. QIWI appointed Maria Shevchenko as Deputy CEO.
  • Aduro BioTech Inc (NASDAQ: ADRO) dropped 10.9% to $1.0250 after William Blair downgraded the stock from Outperform to Market Perform.
  • Allakos Inc. (NASDAQ: ALLK) fell 10.8% to $118.28.
  • EHang Holdings Limited (NASDAQ: EH) dipped 10.6% to $9.90.
  • FedEx Corporation (NYSE: FDX) fell 10% to $146.92 after the company reported worse-than-expected Q2 results and issued soft FY20 guidance.
  • ADDvantage Technologies Group, Inc. (NASDAQ: AEY) dropped 9.7% to $2.4550 after reporting Q4 results.
  • Hebron Technology Co., Ltd. (NASDAQ: HEBT) dipped 9.3% to $6.44.
  • TherapeuticsMD, Inc. (NASDAQ: TXMD) dropped 9.2% to $2.27.
  • The Toro Company (NYSE: TTC) shares declined 8.6% to $73.92 after the company reported downbeat Q4 sales.
  • Communications Systems, Inc. (NASDAQ: JCS) fell 8.5% to $6.68.
  • NantKwest, Inc. (NASDAQ: NK) shares fell 8.4% to $3.5001.
  • Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) dropped 8.2% to $3.80.
  • BioNTech SE (NASDAQ: BNTX) fell 7.9% to $34.00 after rising 5.46% on Tuesday.
  • Aurora Cannabis Inc. (NASDAQ: ACB) dropped 6.2% to $2.2040 after the Italian Government announced it plans to lesson imports on Medical Marijuana in 2020.
  • Global Blood Therapeutics, Inc. (NYSE: GBT) fell 5.3% to $73.67 after the company announced it has entered to in a collaboration agreement with Syros Pharmaceuticals to discover, develop and commercialize novel therapies for sickle cell disease and beta thalassemia. The company will pay Syros $20 million upfront and fund up to $40 million in preclinical research for at least three years.

Related Articles (ADMS + ACB)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at